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INTRODUCTION
An increasing number of patients are suffering from verte-
bral compression and destructive lesions from osteoporosis
and cancer in the aging society. Although the optimum time
for the procedure is controversial, percutaneous vertebroplasty
(PVP) or kyphoplasty is a the key technique to reduce life-
threatening pneumonia, urinary tract infection and other
complications from prolonged bed rest and unrelieved back
and radiating flank, abdomen and groin pain (1). PVP with
or without uni- or bi-lateral facet joint blocks gives the patient
immediate pain relief and it also allows fast recovery of ambu-
lation. 
Excluding 30 cases of operations by bipedicular approaches,
we reviewed 500 patients who had undergone PVP at 612
vertebral levels in terms of the criteria of patient selection,
operation technique, clinical outcomes and the follow-up
course including medication and the medial branch lesion-
ing of the posterior ramus. 
MATERIALS AND METHODS
This study was approved by the Ethics Committee for Hu-
man Study of Pusan National University Hospital, and in-
formed consent was obtained from each patient. After exclu-
ding 30 cases of operations by bilateral pedicular approach
without the concept of radicular pain due to facet joint load-
ing, a total of 500 patients suftering from vertebral compres-
sion and destructive fractures from osteoporosis and cancer had
PVP with or without facet joint blocks for two years. 
We analyzed the period of pain, numeric rating scale (NRS)
scores for pain, Oswestry Disability Index (ODI) except the
data about sex life, and Karnofsky performance status (KPS)
before and after the procedure. 
Neurologic examinations were performed to rule out other
disorders. Supraspinous tenderness was marked with a paper
clip for vertebroplasty, and adjacent facet joint tenderness was
pointed with a marking pencil for facet joint block in prone
position. CT or MRI and radioactive bone scan were done. For
the performance of the unipedicular approach, we measured
the angle and distance from the midline on the skin from the
CT or MRI.
Basic laboratory tests for preoperative workup and for post-
operative follow-up included coagulation tests, liver and renal
function tests, and bone mineral density (BMD).
On operation, we performed uni- or bilateral facet joint
blocks before PVP according to the complaint of patients,
usually neighboring the lesion of the vertebrae.
Lidocaine (1%) was infiltrated from the skin to periosteum
near the pedicle under the fluoroscopic guidance. We perfor-
med epidural analgesia before or during the procedure around
the level of stable vertebral fractures in some patients who
could not maintain a prone position. And we injected 30 mg
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Percutaneous Vertebroplasty and Facet Joint Block
It is surprising that about 24% of patients with benign osteoporotic vertebral fracture
die within a year from respiratory infection and urinary tract infection because of
coughing and voiding difficulties, depending on the sites of compression fractures.
We reviewed 500 patients on whom percutaneous vertebroplasty (PVP) was per-
formed, at 612 levels in terms of patient selection, operation technique, medication,
and clinical outcomes during the follow-up course for 2 yr study period. To confirm
the most painful level among the multiple fracture sites, physical examination after
facet joint block under the fluoroscope was the most reliable method. The mean total
lumbar spine fracture threshold of bone mineral density was 0.81±0.05 g/cm2. The
mean changes of numeric rating scale scores, Oswestry Disability Index except sex
life, and Karnofsky performance status were -72.00, -83.50 and +60.62% in the os-
teoporosis group and -51.89, -45.02, and 69.03% in the tumor group. Complications
related to the procedure were lateral spinal cord damage, transient paresthesia and
transient hypotension. PVP with facet joint block is a profitable method for the ver-
tebral compression fracture because of low risk and short duration of procedure with
a high chance to result in pain relief and early mobilization. 
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ketorolac and 50  g of fentanyl intravenously. In some pa-
tients who complained of severe anxiety about the procedure,
we gave 2-3 mg of midazolam intramuscularly before the
procedure or intravenously during the procedure.
Under the fluoroscope, the entry point of local anesthetic
needle and 11 gauge out-diameter 10 cm length vertebroplasty
needle (J-type Bone Marrow Needle
�, Manan Medical Prod-
uct, Wheeling, IL, U.S.A.) became the meeting point of tra-
jectory line from the pedicle to the body in the lateral view
and sagittal line away from the midline in the antero-poste-
rior (AP) view. The distance from the midline to sagittal line
was determined by CT or MRI.
From the AP view, the target point was the upper lateral
part of the pedicle. A small incision was made with No. 15
scalpel. Under the lateral view of fluoroscope, a vertebral nee-
dle was advanced carefully through the pedicle by manual
turning and pressing of a handle without a hammer. The final
reaching point would be anterior 1/4 to 1/3 on the lateral view
and midline of the vertebral body on the AP view. Under con-
tinuous monitoring using the fluoroscope, the contrast medi-
um was injected through the vertebral needle and any evidence
of leakage of contrast media to intravenous and epidural space
was checked. After testing of the filling into the body and leak-
age into the intravenous and epidural space of contrast media,
antibiotics-containing polymethyl methacrylate (PMMA) ce-
ment was injected by using an injector. The whole injection
procedure was monitored with a continuous fluoroscopy to
avoid possible leakage. The skin was closed by skin closure
(Steri-Strip
�, 3M, St. Paul, MN, U.S.A.) and piroxicam patch
(Trast Patch
�, SK Pharma., Seoul, Korea). 
For 2 hr after the procedure, hypotension, dyspnea, and
sensory or motor problems were checked in the recovery room,
and we asked patients to walk with help, and when possible
the patient was discharged. 
The patients were followed-up at 1 week, 1, 2, 3, 6, 9, and
12 months after the procedure. We measured the BMD of
lumbar spine and femur every 3 months.
After the procedure, the major analgesics for the pain con-
trol were changed from codeine-paracetamol-ibuprofen mix-
ture (Myprodol
�, Adcock Ingram Pharmaceuticals, Johannes-
burg, South Africa) to tramadol-acetaminophen mixture (Ul-
tracet
�, Janssen Korea, Whasung, Korea) for 1 week, and then
we usually stopped the analgesic administration. Medication
for osteoporosis was 70 mg of alendronate sodium (Fosamax
�,
Merck Sharp & Dohne, de Mexido, S. A de C.V, Mexico) week-
ly with or without 60 mg of raloxifene HCl (Evista
�, Eli Lily
& Co, Hamsphire, U.K.) daily. BMD was measured by dual
energy radiography absorptiometry (DEXA, Lunar PRODI-
GY, GE System, Madison, WI, U.S.A.) at 3-month intervals.
After facet joint blocks, we evaluated the period of relapse
of symptoms and the need for denervation of medial branch
of posterior ramus. 
Unless indicated otherwise, the data were presented as mean
±SD. The data were analyzed by using Wilcoxon signed
rank test of nonparametric test for therapeutic effects includ-
ing NRS, ODI, and KPS before and after PVP with facet joint
block between the osteoporosis and tumor groups and for the
comparison of combination effects of alendronate and raloxi-
fene in osteoporosis. 
RESULTS
In 500 patients, PVP was performed on 612 vertebral levels
with or without facet joint blocks during the 2-yr study peri-
od. The demographic data of the patients are shown in Table 1.
Before the procedure, 10 patients suffered from pneumo-
nia, 7 patients complained of voiding difficulties, and 4 pa-
tients had mild dementia due to posttraumatic organic dis-
order after the osteoporotic vertebral compression fractures. 
After conservative treatment with corset and medication
for 2 weeks, 96.2% (500/520) of patients wanted to receive
PVP because of insufficient pain control.
Eighty eight percent of patients (440/500) who complained
of radicular pain to the flank, abdomen, or the buttock, recei-
ved uni- or bilateral facet joint block around the fractured ver-
tebrae before PVP. In 30 cases of patients by bilateral pedic-
ular approach without the concept of the radicular pain due
to facet joint loading, the mean reduction of ODI except sex
life, NRS scores for pain and KPS were 56.1±8.8%, 3.5±
1.2, and 42.2±12.6, compared with 82.2±11.2%, 5.4±
1.3 and 52.3±14.5 in subsequent 500 cases of patients with
who had simultaneous facet joint block. 
The distribution of vertebral levels of operations and pedicle
width, angle and distance from the midline on the skin from
the CT or MRI targeting to the anterior 1/3 to 1/4 for PVP
with unipedicular approach are shown in Table 2 and Table 3.
It was possible to perform unipedicular approach from T4
Osteoporosis
Male 34 68.8±11.6 65.7±5.5 167.3±5.5 Primary 1 57.0±17.4 66.5±11.4 169.5±7.6
(n=46) Secondary 11 65.5±11.4 57.5±8.3 168.5±3.7
Female 374 67.7±7.8 51.4±9.5 154.4±8.8 Primary 2 45.0±15.0 49.5±5.0 163.5±5.5
(n=454) Secondary 78 44.8±7.8 51.1±9.4 158.5±6.5
Table 1. Demographic data of the study subjects (n=500)
Values represent mean ±SD. n, number of patients.
Sex
(n=408) n
Age
(yr)
Body weight
(kg)
No.
Classifi-
cation
(n=92)
Height
(cm)
Body weight
(kg)
Age
(yr)
Height
(cm)
TumorPVP and Facet Joint Block 1025
to L5 level. During the procedure, 74.3% (455/612) levels
showed epidural and/or vascular leakage of contrast media
under the fluoroscopy.
The mean changes of NRS scores for pain, ODI except sex
life, and KPS were -72.00, -83.50 and +60.62% in the osteo-
porosis group and -51.89, -45.02, and +69.03% in the tumor
group (Table 4). 
As for the diagnostic tools to pinpoint the painful levels
among the multiple fractures, plane radiography film, CT or
MRI, and bone scan showed discrepant results. To confirm
the most painful level among the multiple fracture sites and
to get the clinical success to relieve pain, physical examina-
tion after facet joint block under the fluoroscope was the most
reliable method. 
During the follow-up course, 60% (264/440) of the pa-
tients who received facet joint block complained of recurring
radicular pain in 3.5±1.2 months (range, 1.8 to 11.2 mon-
ths). Among them, 50% (132/264) received conventional ra-
diofrequency ablation. 
Complications related to the procedure were 1 case of later-
al spinal cord syndrome on L1, 3 cases of transient paresthe-
sia for 1 week, and 1 case of severe hypotension (70/40 mmHg)
with bradycardia related to anterior leakage to the sympathetic
nerves, which was immediately recovered by ephedrine. 
The mean changes of lumbar spine and femoral neck BMD
after 3 and 6 months of treatment with alendronate (ALN)
with or without raloxifene (RLX) in the osteoporotic group
were shown in Table 5. 
DISCUSSION
With regard to conservative treatment which includes bed
rest, analgesic medication, and orthotics, conservative thera-
py takes a long time and can cause difficult problems. Uncon-
trolled continuous pain can cause difficulties in coughing and
mobilization, which finally leads to respiratory and urinary
tract infection and eventual possible dementia. trauma toward
dementia. We should consider spinal fracture as a major trau-
Level
of site
T4 0 0 2 124
T5 0 0 1 (20.26%)
T6 21 1 0
T7 10 1 1
T8 21 0 0
T9 42 1 0
T10 22 1 0
Subtotal 116 4 4
(18.95%) (0.65%) (0.65%)
T11 63 0 32 370
T12 84 0 21 (60.46%)
L1 105 0 11
L2 41 0 13
Subtotal 293 0 77
(47.88%) (12.58%)
L3 41 0 5 118
L4 33 0 6 (19.28%)
L5 21 0 12
Subtotal 95 0 23
(15.52%) (3.76%)
Total 504 108 612
(82.35%) (17.65%) (100%)
Table 2. The distribution of 612 vertebral levels in 500 patients
who underwent percutaneous vertebroplasty with joint block ac-
cording to the patient group
Osteo-
porosis Secondary Primary
Tumor
Subtotal
Width of Smallest  Largest  Shortest Longest
Level pedicle angle angle distance distance
(cm) (°) (°) (cm) (cm)
T4 0.29±0.10 19.25±1.10 28.06±2.70 2.45±0.50 3.55±0.50
T5 0.30 19.50 29.00 2.53 3.60
T6 0.33±0.10 17.42±2.14 28.85±1.87 2.51±0.39 4.09±0.48
T7 0.39±0.12 18.72±2.11 28.82±1.87 2.46±0.56 3.56±0.39
T8 0.44±0.11 17.33±3.20 29.20±1.97 2.37±0.55 3.26±0.60
T9 0.55±0.13 16.50±2.60 28.86±1.88 2.27±0.45 3.39±0.51
T10 0.64±0.90 16.25±2.00 29.33±1.72 2.21±0.52 3.41±0.41
T11 0.70±0.15 18.42±3.06 32.05±3.22 2.38±0.36 3.81±0.49
T12 0.74±0.20 20.62±2.62 34.20±2.86 2.61±0.52 4.30±0.81
L1 0.78±0.23 20.37±2.93 32.54±2.28 2.58±0.45 4.17±0.61
L2 0.81±0.22 21.00±2.88 33.96±3.29 2.91±0.39 4.80±0.98
L3 0.84±0.35 21.37±2.96 34.53±3.61 3.40±0.78 5.50±1.28
L4 0.88±0.44 22.18±3.98 36.96±3.86 3.38±0.71 5.87±1.01
L5 1.21±0.48 23.95±4.68 44.45±8.52 3.43±0.58 6.82±1.25
Table 3. Pedicle width, angle and distance from the midline on
the skin on CT or MRI targeting to the anterior midline 1/3 to 1/4
for PVP with unipedicular approach 
Osteoporosis (n=408) Tumor (n=92) p value
NRS (-5.4/7.5) * 100=-72.00% (-4.1/7.9) * 100=-51.89% 0.0015
ODI (-25.3/30.3) * 100=-83.50% (-27.1/60.2) * 100=-45.02% 0.0017
KPS (+29.4/48.5) * 100=+60.62%(+29.2/42.3) * 100=+69.03%0.0056
Table 4. Mean changes of numeric rating scale (NRS), Oswestry
disability index (ODI), and Karnofsky performance status (KPS)
after percutaneous vertebroplasty (PVP) with uni- or bi-lateral fa-
cet joint blocks
Site Duration
ALN ALN + RLX  p
(n=100) (n=100) value
Lumbar Baseline (g/cm2) 0.70±0.06 0.69±0.10 0.5834
spine 3 month (%) 4.74±0.60 6.81±0.53 0.1714
(L1-4) 6 month (%) 7.11±0.61 8.72±0.44 0.1524
Femoral Baseline (g/cm2) 0.56±0.07 0.57±0.72 0.4537
neck 3 month (%) 4.63±0.52 5.28±0.07 0.2117
6 month (%) 5.62±0.91 8.01±1.21 0.0108
Table 5. Mean changes from the baseline in lumbar spine and
femoral neck bone mineral density after 3 and 6 months of treat-
ment with alendronate (ALN) with or without raloxifene (RLX) in
the osteoporotic group by DEXAma in one’s life. Therefore, we tried to reduce hospital stay
much as possible to minimize patients’ maladaptation from
life-style including space (home to hospital), caring person
(family to nursing personnel), and time (including sleeping
and feeding). 
For multiple osteoporotic or metastatic fractures, it was to
decide the order of PVP procedure. Gaughen et al. (2) took
the evidence of edema on MRI or increased uptake on bone
scan rather than preoperative spinous process tenderness as
affecting the clinical success of PVP. In our experience, the
level of PVP in multiple spine fractures was not radiography
film, active lesions on the bone scan, or MRI. Checking the
thoracic or lumbar plain series with paper clip markings on
the back had a gap because maximal tenderness point on phy-
sical examination in prone position was different from that
of the films in erect position. There were usually intractable
spinous tenderness below two or three levels from the levels
on plain films. Despite multiple levels of active lesions on
bone scan and edema on MR, the range of intractable painful
sites requiring vertebroplasties were smaller. 
Facet joint block before PVP had two major roles, one was
to let patients lie down during the procedure under the local
anesthesia and the other was to let the operator find out the
exact level among the multiple fractures by elimination of ra-
diating pain to the flank, abdomen, groin or buttock. It should
be reminded that performing PVP over the three levels simul-
taneously will increase the risk of asymptomatic leakage of
cement, and most of patients cannot endure the prone posi-
tion during the procedure. 
In 88% (440/500) of patients who complained of radicular
pain to the flank, abdomen, or buttock, uni- or bilateral facet
joint block around the fractured vertebrae was essential prior
to PVP because the injected bone cement obscured the adja-
cent facet joints, and radicular pain would be decreased to a
tolerable level during PVP. Our choice to select the correct
level among the multiple fractures was spinous process ten-
derness under the fluoroscope by the aid of facet joint block
before PVP for the best clinical outcomes.
Leakage of cement into the intravenous and epidural space
would be a threatening condition. To reduce the risk and oper-
ating time, first of all, continuous monitoring of filling and
leakage of contrast media and cement under the fluoroscopic
guidance is most important, even though the risk of radiation
hazard is increased. Second, if only leakage of contrast media
occurs without the evidence of filling into the body, inserting
2-3 slices of absorbable gelatin sponge (Spongostan
�, John-
son & Johnson Medical Limited, Gargrave, Skipton, U.K.)
through the vertebral needle is helpful to reduce the chance
of leakage into the venous and epidural space. Epidural and/or
vascular leakages of contrast media occurred on 455/612 levels
(74.3%). After filling with gelatin in the vertebroplasty nee-
dle, 2-3 mL of normal saline was injected and the appearance
of filling and leakage of contrast media was observed again.
At least, confirmation of filling the vertebral body first and
subsequent small leakage into the venous and epidural space
would be an acceptable condition to inject cement. Third, it
is better to push the needle in rather than pull back when the
needle contacted with vessels and filled with blood in aspira-
tion despite the insertion of absorbable gelatin sponge. Fourth,
abandon to inject more volume of cement for the intensity of
the body of the vertebra. The introduction of 20% bone ce-
ment by volume results in a significant increase in the com-
pressive strength of intact lumbar vertebrae; however, upper
thoracic vertebrae do not demonstrate a similar improvement
in strength. There was no difference in the stiffness of the ver-
tebrae injected with cement regardless of location. Cement
leakage was frequently noted with 20% cement injection, es-
pecially in the specimens with higher BMD. The location of
the cement did not appear to have an effect on the loading
behavior of the bone but should be controlled to minimize
the chance of cement escaping into the spinal canal (3). From
to this article and our experience, in the metastatic compres-
sion fractures with higher BMD, the increase of the temper-
ature and resultant ablation of the nerve endings of the sino-
vertebral and sympathetic nerves around the body could be
the important mechanisms to reduce pain than the strength
improvement due to a volume increase. After the diagnosis
of bone metastasis, the median survivals were 12 months in
patients with breast carcinoma, 6 months in patients with
prostate carcinoma, and 3 months in patients with lung car-
cinoma (4). According to other reports, the median survival
rate was 48 months when metastases were confined to the
skeletal system in patients with breast carcinoma, but it de-
creased to only 9 months if visceral metastases were also pre-
sent (5). Finally, barium sulfate mixed with the cement would
be helpful for observing the appearance of filling the body
despite unknown foreign body reaction and somewhat reduced
degree of strength augmentation. 
During the follow-up course, 60% (264/440) of the pa-
tients who received facet joint block complained of recurring
radicular pain in 3.5±1.2 months (range, 1.8 to 11.2 mon-
ths). Among them, 50% (132/264) received conventional ra-
diofrequency ablation, 90℃ for 90 sec with 10 mm active
tip and 10 cm long, on the medial branches of the posterior
ramus. The patients who received radiofrequency ablation did
not experience recurrence of the symptom or neuropathic pain
related the neural ablation within 6 months. Further long-
term follow-up study is necessary. 
For past several years, a patient who could not lie in prone
position during the procedure was not considered a good can-
didate for PVP. However, we kept a continuous epidural ca-
theter and reduced pain with local anesthetics before the pro-
cedure after checking MRI and CT films and then removed
it after the procedure. Intractable pain and inability to take
a suitable position during PVP procedure are not contraindi-
cations any more. 
The entry point of the needle should be the upper lateral
part of the pedicle on the AP view of fluoroscope to reduce
1026 T.-K. Kim, K.-H. Kim, C.-H. Kim, et al.the risk of nerve root damage below the pedicle and cord da-
mage medial to the pedicle. If a needle with single bevel sha-
ped stylet (6) is used for PVP, it is important to turn the direc-
tion of bevel upward or downward, which will determine the
final end point of the needle. 
Before the injection of cement, a small amount of local anes-
thetics, 1 mL of 1% lidocaine, reduced the pain associated
with volume expansion without complications. For an esthetic
view and wound care, a small transverse incision along the
crease of the back for introducing the vertebral needle with
# 15 scalps was better than bruising with a dull 11-gauge
needle without incision. And after finishing the procedure,
skin closure without suture and piroxicam patch for 2 days’
analgesia were applied on the wound. There was no skin
wound infection or osteomyelitis despite no more dressing
on the wound and no antibiotic medication. Most of patients
could take a shower one week after their first visit to the
outpatient department. 
Preoperative medications were a codeine-containing mix-
ture including acetaminophen and ibuprofen, muscle relax-
ants, and alendronate with or without raloxifene according
to their economic status and contraindications. After the pro-
cedure, the major analgesic medication was changed into tra-
madol-acetaminophen mixture. Patients who complained of
radicular pain related to facet joint syndrome were prescribed
gabapentin and/or amitriptyline or nortrityline before and
after the facet joint blockade. 
Complications related to the procedure were 1 case of lat-
eral spinal cord syndrome on L1 that occurred while trying
to aim the vertebral needle to the midline of the body on the
unipedicular approach, 3 cases of transient paresthesia for 1
week, and 1 case of severe hypotension (70/40 mmHg) with
bradycardia related to anterior leakage to the sympathetic ner-
ves, which was immediately recovered by ephedrine. Accord-
ing to the Society of Interventional Radiology (SIR) Quality
Improvement Guidelines for PVP using SIR Standards of
Practice Committee Classification of Complications of by Out-
come, there were 1 case in the class D of major complications
(Require major therapy, unplanned increase in level of care,
prolonged hospitalization over 48 hr) and 3 cases in the class
B of minor complications (Normal therapy, no consequence,
includes overnight admission for observation only) (7). 
As for the mechanism of pain relief in PVP, the sensory role
of nerve endings within compact bone has become the focus
for two reasons. First, increasing the rigidity of the bone throu-
gh the injection and subsequent hardening of PMMA cement
is expected to reduce bone deformation during weight bear-
ing, and hence to reduce the mechanical forces applied to no-
ciceptive endings within the bone. Second, since the cement
itself is toxic for the nerve tissue, PVP causes at least partial
denervation of the bone matrix (8). Facet joint pain radiating
to the dermatome is a neuropathic pain of the medial branch
of posterior ramus probably originating from the tightened
narrow space between the superior and inferior articular pro-
cesses.
A few patients showed mixed features of osteoporosis and
tumor on the vertebrae. We tried to identify the nature of the
disease-causing compression fracture by using bone marrow
aspiration biopsy during PVP. There was no tumor cell on the
aspirate smear and cell block among all the specimens. Non-
specific acute and chronic inflammations were found in only
three osteoporotic specimens. It was impossible to get tumor
cells in the primary or secondary tumorous vertebral compres-
sion fracture by aspiration biopsy. Instead of using the aspira-
tion biopsy, bone tissue punch biopsy by trephine needle
would be helpful to prove the cause of vertebral compres-
sion fracture (9). 
Some doctors believe that PVP causes new fractures adja-
cent to the initial level of PVP because diminishment of the
compliance of one vertebra by means of cement injection may
place the remainder of the axial skeleton at greater risk for
collapse. However Kallmes and Jensen (6) reported that one-
half of new fractures were occurring adjacent to the initial
PVP level, but 68% of fractures in multiple osteoporotic frac-
tures were at contiguous levels before the PVP. We do agree
that there is no evidence of increasing risk of new fracture by
preceding PVP. In our opinion, it is more important rather
to improve the BMD score than to be concerned about the
risk of subsequent fracture after PVP. 
Similar to the results from a to previous study (10), combi-
ned treatment with alendronate and raloxifene resulted in
greater increase of BMD than the single-agent group (11). If
the combination regimen is not affordable, alendronate is our
choice to increase by one standard deviation BMD and to re-
duce the risk of new fracture after PVP. Known predictive
fracture risk decrease in BMD by one standard deviation at
spine and hip were 2.3 and 2.6 respect 1.5 to all other sites
(12, 13). Raloxifene was added to alendronate, except in male
patients and patients with breast cancer (14). 
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